Relay Therapeutics Inc (NASDAQ: RLAY) Has Slid Negatively For The Year To Date, Predicting What Will Happen Next
Relay Therapeutics Inc (NASDAQ:RLAY)’s traded shares stood at 1.28 million during the last session, with the company’s beta value hitting 1.64. At the close of